Philippe Wiesel

2.5k total citations
20 papers, 1.8k citations indexed

About

Philippe Wiesel is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Philippe Wiesel has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Immunology. Recurrent topics in Philippe Wiesel's work include Heme Oxygenase-1 and Carbon Monoxide (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Philippe Wiesel is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Philippe Wiesel collaborates with scholars based in United States, Switzerland and United Kingdom. Philippe Wiesel's co-authors include Mark A. Perrella, Shaw‐Fang Yet, Andrea Pellacani, Mu-En Lee, Koji Maemura, Matthew D. Layne, Chung-Ming Hsieh, Lucia Mazzolai, Jürg Nussberger and Thierry Pedrazzini and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Philippe Wiesel

19 papers receiving 1.7k citations

Peers

Countries citing papers authored by Philippe Wiesel

Since Specialization

Citations

This map shows the geographic impact of Philippe Wiesel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Wiesel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Wiesel more than expected).

Fields of papers citing papers by Philippe Wiesel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Wiesel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Wiesel. The network helps show where Philippe Wiesel may publish in the future.

Co-authorship network of co-authors of Philippe Wiesel

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Wiesel. A scholar is included among the top collaborators of Philippe Wiesel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Wiesel. Philippe Wiesel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1118a: A PHASE 2A, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF AGMB-129 IN PATIENTS WITH FIBROSTENOTIC CROHN’S DISEASE: INTERIM RESULTS FROM THE STENOVA TRIAL 2025 ·Gastroenterology ·(unknown), Julián Panés, Brian G. Feagan, (unknown), Jarosław Kierkuś, Cathy Lu, (unknown), (unknown), Kim Thys, Reginald Brys, Margreke J. E. Brill, C. Fleurinck, Rolf van Heeswijk, (unknown), (unknown), Philippe Wiesel	0
2	Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial 2023 ·Liver International ·Pietro Invernizzi, Marco Carbone, David Jones, Cynthia Levy, (unknown), Philippe Wiesel, Frederik Nevens, (unknown)	37
3	Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial 2023 ·Hepatology Communications ·David Jones, Marco Carbone, Pietro Invernizzi, (unknown), Frederik Nevens, Mark G. Swain, Philippe Wiesel, Cynthia Levy	22
4	Targeting the NADPH Oxidase-4 and Liver X Receptor Pathway Preserves Schwann Cell Integrity in Diabetic Mice 2019 ·Diabetes ·Stéphanie Eid, (unknown), (unknown), (unknown), Julien Grenier, Batoul Dia, (unknown), (unknown), J. Chanal, S. Aractingi, Philippe Wiesel, Cédric Szyndralewiez, Sami T. Azar, Christian Boîtard, Ghazi Zaatari, Assaad A. Eid, Charbel Massaad	34
5	Therapeutic potential of NADPH oxidase 1/4 inhibitors 2016 ·British Journal of Pharmacology ·Graciosa Q. Teixeira, Cédric Szyndralewiez, (unknown), Stéphanie Carnésecchi, Freddy Heitz, Philippe Wiesel, J M Wood	136
6	Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial 2008 ·Arthritis & Rheumatism ·Sylviane Muller, Fanny Monneaux, Nicolas Schall, Rasho Rashkov, (unknown), Philippe Wiesel, (unknown), Robert Zimmer	94
7	Down-regulation of High Mobility Group-I(Y) Protein Contributes to the Inhibition of Nitric-oxide Synthase 2 by Transforming Growth Factor-β1 2001 ·Journal of Biological Chemistry ·Andrea Pellacani, Philippe Wiesel, (unknown), (unknown), Mark W. Feinberg, Michael T. Chin, Raymond Reeves, Mark A. Perrella	29
8	Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice 2001 ·Circulation Research ·Philippe Wiesel, Anand Patel, Irvith M. Carvajal, (unknown), Andrea Pellacani, Koji Maemura, (unknown), Helmut G. Rennke, Matthew D. Layne, Shaw‐Fang Yet, Mu-En Lee, Mark A. Perrella	87
9	Transforming Growth Factor-β1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in Macrophages 2000 ·Journal of Biological Chemistry ·(unknown), Mark W. Feinberg, (unknown), Nicholas Sibinga, Philippe Wiesel, Hong Wang, James N. Topper, Mark A. Perrella, Mu-En Lee	143
10	Thioredoxin Facilitates the Induction of Heme Oxygenase-1 in Response to Inflammatory Mediators 2000 ·Journal of Biological Chemistry ·Philippe Wiesel, Lauren C. Foster, Andrea Pellacani, Matthew D. Layne, Chung-Ming Hsieh, Gordon S. Huggins, Phyllis R. Strauss, Shaw‐Fang Yet, Mark A. Perrella	107
11	Role of activating protein‐1 and high mobility group‐I(Y) protein in the induction of CD44 gene expression by interleukin‐1β in vascular smooth muscle cells 2000 ·The FASEB Journal ·Lauren C. Foster, Philippe Wiesel, Gordon S. Huggins, (unknown), Michael T. Chin, Andrea Pellacani, Mark A. Perrella	45
12	Transforming Growth Factor-β1 Inhibition of Macrophage Activation Is Mediated via Smad3 2000 ·Journal of Biological Chemistry ·(unknown), Mukesh K. Jain, Mark W. Feinberg, Nicholas Sibinga, Andrea Pellacani, Philippe Wiesel, Michael T. Chin, James N. Topper, Mark A. Perrella, Mu-En Lee	146
13	Endotoxin-Induced Mortality Is Related to Increased Oxidative Stress and End-Organ Dysfunction, Not Refractory Hypotension, in Heme Oxygenase-1–Deficient Mice 2000 ·Circulation ·Philippe Wiesel, Anand Patel, (unknown), (unknown), (unknown), Andrea Pellacani, Koji Maemura, Brian W. LeBlanc, (unknown), Claire M. Doerschuk, Shaw‐Fang Yet, Mu-En Lee, Mark A. Perrella	163
14	Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice 1999 ·Journal of Clinical Investigation ·Shaw‐Fang Yet, Mark A. Perrella, Matthew D. Layne, Chung-Ming Hsieh, Koji Maemura, Lester Kobzik, Philippe Wiesel, Helen Christou, Stella Kourembanas, Mu-En Lee	339
15	Induction of High Mobility Group-I(Y) Protein by Endotoxin and Interleukin-1β in Vascular Smooth Muscle Cells 1999 ·Journal of Biological Chemistry ·Andrea Pellacani, Michael T. Chin, Philippe Wiesel, Maureen Ibanez, Anand Patel, Shaw‐Fang Yet, Chung-Ming Hsieh, Joseph Paulauskis, Raymond Reeves, Mu-En Lee, Mark A. Perrella	36
16	High Mobility Group-I(Y) Protein Facilitates Nuclear Factor-κB Binding and Transactivation of the Inducible Nitric-oxide Synthase Promoter/Enhancer 1999 ·Journal of Biological Chemistry ·Mark A. Perrella, Andrea Pellacani, Philippe Wiesel, Michael T. Chin, Lauren C. Foster, Maureen Ibanez, Chung-Ming Hsieh, Raymond Reeves, Shaw‐Fang Yet, Mu-En Lee	53
17	Aortic Connexin43 Is Decreased During Hypertension Induced by Inhibition of Nitric Oxide Synthase 1999 ·Arteriosclerosis Thrombosis and Vascular Biology ·Jacques‐Antoine Haefliger, Paolo Meda, Andrea Formenton, Philippe Wiesel, Anne Zanchi, Hans R. Brunner, Pascal Nicod, Daniel Hayoz	54
18	Induction of Heme Oxygenase-1 During Endotoxemia Is Downregulated by Transforming Growth Factor-β1 1998 ·Circulation Research ·Andrea Pellacani, Philippe Wiesel, (unknown), Lauren C. Foster, Gordon S. Huggins, Shaw‐Fang Yet, Mark A. Perrella	53
19	Time Course Changes of the Mechanical Properties of the Carotid Artery in Renal Hypertensive Rats 1997 ·Hypertension ·Anne Zanchi, Philippe Wiesel, Jean-François Aubert, Hans R. Brunner, Daniel Hayoz	26
20	Two-Kidney, One Clip and One-Kidney, One Clip Hypertension in Mice 1997 ·Hypertension ·Philippe Wiesel, Lucia Mazzolai, Jürg Nussberger, Thierry Pedrazzini	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact